Skip to main content
. 2021 Sep 24;13(10):1555. doi: 10.3390/pharmaceutics13101555

Figure 1.

Figure 1

The flow chart of the study design for in silico identification of potential targets for Alzheimer’s disease and antrocin as a therapeutic candidate.